(Q37665308)

21 August 2017

1 reference

title

Key factors in the discovery and development of new antiepileptic drugs (English)

1 reference

21 August 2017

Meir Bialer

1

1 reference

21 August 2017

H Steve White

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2010

1 reference

Nature Reviews Drug Discovery

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

68-82

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2997

21 August 2017

exact match

0 references

cites work

Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy

1 reference

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).

31 March 2020

1 reference

New antiepileptic drugs that are second generation to existing antiepileptic drugs

31 March 2020

1 reference

Likelihood of seizure remission in an adult population with refractory epilepsy

31 March 2020

1 reference

Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

31 March 2020

1 reference

Diverse mechanisms of antiepileptic drugs in the development pipeline

31 March 2020

1 reference

Discovery of antiepileptic drugs

31 March 2020

1 reference

New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels

31 March 2020

1 reference

Development of new antiepileptic drugs: challenges, incentives, and recent advances

31 March 2020

1 reference

Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels

31 March 2020

1 reference

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

31 March 2020

1 reference

Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.

31 March 2020

1 reference

SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

31 March 2020

1 reference

In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models

31 March 2020

1 reference

Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

31 March 2020

1 reference

The role of cytokines in the pathophysiology of epilepsy

31 March 2020

1 reference

Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis

31 March 2020

1 reference

Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy

31 March 2020

1 reference

Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy

31 March 2020

1 reference

A role for leukocyte-endothelial adhesion mechanisms in epilepsy

31 March 2020

1 reference

Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis

31 March 2020

1 reference

Barrier to electrical storms

31 March 2020

1 reference

Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat.

31 March 2020

1 reference

Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder

31 March 2020

1 reference

Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain

31 March 2020

1 reference

Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice

31 March 2020

1 reference

Valproic Acid: second generation

31 March 2020

1 reference

The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models

31 March 2020

1 reference

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy

31 March 2020

1 reference

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

31 March 2020

1 reference

Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission

31 March 2020

1 reference

31 March 2020

1 reference

Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse

31 March 2020

1 reference

New frontiers in the pharmacological management of Parkinson's disease

31 March 2020

1 reference

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

31 March 2020

1 reference

Neuroprotective agents for clinical trials in ALS: a systematic assessment

31 March 2020

1 reference

Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model

31 March 2020

1 reference

N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activities

31 March 2020

1 reference

Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy

31 March 2020

1 reference

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

31 March 2020

1 reference

Lacosamide: a review of preclinical properties.

31 March 2020

1 reference

Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy.

31 March 2020

1 reference

31 March 2020

1 reference

Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial

31 March 2020

1 reference

Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS

31 March 2020

1 reference

A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy

31 March 2020

1 reference

The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.

31 March 2020

1 reference

Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons

31 March 2020

1 reference

Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro

31 March 2020

1 reference

Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans

31 March 2020

1 reference

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

31 March 2020

1 reference

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

31 March 2020

1 reference

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity

31 March 2020

1 reference

Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

31 March 2020

1 reference

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study

31 March 2020

1 reference

Pharmacokinetics of licarbazepine in healthy volunteers: single and multiple oral doses and effect of food

31 March 2020

1 reference

31 March 2020

1 reference

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

31 March 2020

1 reference

Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.

31 March 2020

1 reference

Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy

31 March 2020

1 reference

Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain

31 March 2020

1 reference

Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide

31 March 2020

1 reference

Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain

31 March 2020

1 reference

Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives

31 March 2020

1 reference

The Effects of Central Nervous System-Active Valproic Acid Constitutional Isomers, Cyclopropyl Analogs, and Amide Derivatives on Neuronal Growth Cone Behavior

31 March 2020

1 reference

Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy

31 March 2020

1 reference

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters

31 March 2020

1 reference

XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkey

31 March 2020

1 reference

Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin

31 March 2020

1 reference

In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity

31 March 2020

1 reference

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

31 March 2020

1 reference

Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy

31 March 2020

1 reference

Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy

31 March 2020

1 reference

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

31 March 2020

1 reference

Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.

31 March 2020

1 reference

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

31 March 2020

1 reference

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

31 March 2020

1 reference

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

31 March 2020

1 reference

Screening and characterization of antiepileptic drugs with rapidly recurring hippocampal seizures in rats

31 March 2020

1 reference

Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats

31 March 2020

1 reference

Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.

31 March 2020

1 reference

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

31 March 2020

1 reference

Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.

31 March 2020

1 reference

Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy

31 March 2020

1 reference

Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats

31 March 2020

1 reference

Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.

31 March 2020

1 reference

Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia

31 March 2020

1 reference

The pharmacologic basis of antiepileptic drug action

31 March 2020

1 reference

Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation

31 March 2020

1 reference

Sodium channel beta1 subunits promote neurite outgrowth in cerebellar granule neurons

31 March 2020

1 reference

Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice

31 March 2020

1 reference

A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.

31 March 2020

1 reference

The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons

31 March 2020

1 reference

Calcium channel beta 4 (CACNB4): human ortholog of the mouse epilepsy gene lethargic

31 March 2020

1 reference

Single gene defects in mice: the role of voltage-dependent calcium channels in absence models

31 March 2020

1 reference

Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability

31 March 2020

1 reference

Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold

31 March 2020

1 reference

Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.

31 March 2020

1 reference

Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

31 March 2020

1 reference

Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction

31 March 2020

1 reference

Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice.

31 March 2020

1 reference

GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons.

31 March 2020

1 reference

Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy

31 March 2020

1 reference

Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis.

31 March 2020

1 reference

Proconvulsant-induced seizures in alpha(4) nicotinic acetylcholine receptor subunit knockout mice

31 March 2020

1 reference

Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.

31 March 2020

1 reference

Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.

31 March 2020

1 reference

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial

31 March 2020

1 reference

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043029

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043029

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043029

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRD2997

1 reference

21 August 2017

1 reference